期刊文献+

微小RNA-142-3p在脓毒症患者血清中的表达及其临床意义 被引量:7

Expression of microRNA-142-3p in serum of septic patients and its clinical significance
原文传递
导出
摘要 目的通过观察脓毒症患者血清中微小RNA-142-3p(miR-142-3p)的表达,探讨其与脓毒症的关系。方法选取41例脓毒症患者作为研究对象,同期住院的非脓毒症患者20例作为对照组。采用实时荧光定量PCR检测血清中miR-142-3p的表达,酶联免疫吸附剂测定(ELISA)检测白细胞介素6(IL-6)和IL-10的表达。采用Spearman相关分析miR-142-3p与患者临床特点和实验室指标的相关性,受试者工作特征(ROC)曲线评价miR-142-3p、IL-6、IL-10、C反应蛋白(CRP)、前降钙素原(PCT)、白细胞计数和乳酸表达水平对脓毒症的预测价值。结果脓毒症组患者的白细胞计数[(14.4±7.8)×109/L vs.(8.4±2.1)×109/L,t=4.571,P <0.001]、CRP[(127±80)mg/L vs.(80±45)mg/L,t=2.436,P=0.018]、乳酸[(2.3±1.8)mmol/L vs.(1.5±0.6)mmol/L,t=2.421,P=0.019]、PCT [5.70 (1.49,26.37)μg/L vs. 0.25 (0.10,0.63)μg/L,Z=75.500,P <0.001]、IL-6 [342.33(64.98,2 618.44)ng/L vs. 14.95(3.21,54.51)ng/L,Z=84.000,P <0.001]、IL-10 [23.16(6.19,85.56)ng/L vs. 2.75(1.39,5.36)ng/L,Z=198.500,P=0.001]和miR-142-3p [95.74(23.19,278.23)vs. 25.64(18.59,56.05),Z=222.000,P=0.004]均显著高于对照组。miR-142-3p与乳酸、IL-6、PCT均呈正相关(r=0.427、0.340、0.309,P=0.005、0.030、0.049)。根据脓毒症患者28 d生存情况分为存活组(29例)和死亡组(12例)。存活组的急性病生理学与长期健康评价(APACHE)Ⅱ评分[(14±6)分vs.(25±6)分]、序贯性器官衰竭估计(SOFA)评分[(6.0±2.8)分vs.(10.7±3.5)分]和乳酸[(1.6±1.0)mmol/L vs.(3.8±2.6)mmol/L]水平均显著低于死亡组(t=5.406、4.482、2.835,P均<0.05)。ROC曲线分析结果显示,miR-142-3p [曲线下面积(AUC)=0.729,95%CI(0.602,0.856),P=0.004]、IL-6 [AUC=0.898,95%CI(0.820,0.975),P <0.001]、CRP [AUC=0.698,95%CI (0.566,0.831),P=0.013]、PCT [AUC=0.908,95%CI(0.835,0.981),P <0.001]、IL-10 [AUC=0.758,95%CI((0.631,0.885),P=0.001]和白细胞计数[AUC=0.776,95%CI(0.659,0.893),P=0.001]对脓毒症均有预测价值。结论脓毒症患者血清中miR-142-3p� Objective To observe the expression of serum microRNA-142-3p (miR-142-3p) in septic patients and to explore its relationship with sepsis. Methods Forty-one patients with sepsis were selected as study subjects, and 20 non-septic patients hospitalized in the same period as the control group. The expression of serum miR-142-3p was detected by real-time quantitative PCR, and levels of interleukin-6 (IL-6) and IL-10 were detected by enzyme-linked immunosorbent assay (ELISA). The relationship between miR-142-3p and septic patients' clinical characteristics and laboratory indexes was analyzed by Spearman correlation analysis. In the same time, the predictive value of miR-142-3p, IL-6, IL-10, C-reactive protein (CRP), procalcitonin (PCT), white blood cell count and lactic acid on sepsis was evaluated by the receiver operating characteristic (ROC) curve. Results The white blood cell count [(14.4 ± 7.8) ×10^9 / L vs. (8.4 ± 2.1) × 10^9 / L, t = 4.571, P 〈 0.001], CRP [(127 ± 80) mg / L vs. (80 ± 45) mg / L, t = 2.436, P = 0.018], lactic acid [(2.3 ± 1.8) mmol / L vs. (1.5 ± 0.6) mmol / L, t = 2.421, P = 0.019], PCT [5.70 (1.49, 26.37) μg / L vs. 0.25 (0.10, 0.63) μg / L, Z = 75.500, P 〈 0.001], IL-6 [342.33 (64.98, 2 618.44) ng / L vs. 14.95 (3.21, 54.51) ng / L, Z = 84.000, P 〈 0.001], IL-10 [23.16 (6.19, 85.56) ng / L vs. 2.75 (1.39, 5.36) ng / L, Z = 198.500, P = 0.001] and miR-142-3p [95.74 (23.19, 278.23) vs. 25.64 (18.59, 56.05), Z = 222.000, P = 0.004] were significantly higher in the sepsis group than in control group. MiR-142-3p was positively correlated with lactic acid, IL-6 and PCT (r = 0.427, 0.340, 0.309; P = 0.005, 0.030, 0.049). Patients with sepsis were divided into the survival group (29 cases) and death group (12 cases) according to their survival conditions on 28 days. The scores of acute physiology and chronic health evaluation (APACHE) Ⅱ [(14 ± 6) vs. (25 ± 6)] and s
作者 李洁 孙敏 乐健伟 陈红 朱建华 Li Jie;Sun Min;Le Jianwei;Chen Hong;Zhu Jianhua(Department of Intensive Care Unit,Ningbo First Hospital,Ningbo 315010,China)
出处 《中华危重症医学杂志(电子版)》 CAS CSCD 2018年第5期310-315,共6页 Chinese Journal of Critical Care Medicine:Electronic Edition
基金 浙江省医药卫生科技计划项目(2017KY585)
关键词 脓毒症 微小RNA-142-3p 血清 Sepsis MicroRNA-142-3p Serum
  • 相关文献

参考文献4

二级参考文献40

  • 1刘清泉.对脓毒症中医病机特点及治法的认识[J].北京中医,2007,26(4):198-200. 被引量:206
  • 2Angus DC,Linde-Zwirble WT,Lidieker J. Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Critical Care Medicine,2001,(07):1303-1310. 被引量:1
  • 3Bone RC,Balk RA,Cerra FB. ACCP/SCCM Consensus Conference Comnittee.Definitions roo sepsis and organ fatilure and guidelines for the use of innovative therapies in sepsis.Review.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Soeiety of Critical Care Medicine[J].Chest,1992,(06):1644-1655. 被引量:1
  • 4Levy MM,Fink MP,Marshall JC. SCCM/ESICM/ACCP/ATS/SIS:2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Critical Care Medicine,2003,(04):1250-1256. 被引量:1
  • 5Rangel-Frausto MS,Pittet D,Costigan M. The natural history of the systenic inflammatory response syndrme (SIRS).A prospectivestudy[J].Journal of the American Medical Association,1995,(02):117-123. 被引量:1
  • 6Bianchi ME. DAMPs,PAMPs and alarmins:all we need to know about danger.Review[J].Journal of Leukocyte Biology,2007,(01):1-5. 被引量:1
  • 7Cavaillon JM,Adib-Conquy M,Cloiz-Tayaruni I. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon:a review[J].Journal of Endotoxin Research,2001,(02):85-93. 被引量:1
  • 8Poeze M,Ramsay G,Gerlach H. An international sepsis survey:a study of doctors' knowledge and perception about sepsis[J].Critical Care,2004,(06):R409-R413. 被引量:1
  • 9Soong J,Soni N. Sepsis:reeognition and treatment[J].Clinical Medicine,2012,(03):276-280. 被引量:1
  • 10Smith GB,Prytherch DR,Schmidt PE. Review and performance evaluation of aggregate weighted ' track and trigger'systems[J].Resuscitation,2008,(02):170-179. 被引量:1

共引文献51

同被引文献57

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部